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Introduction: The UK’s response to the COVID-19 pandemic presented multiple
challenges to healthcare services including the suspension of non-urgent care. The
impact on neurorehabilitation professions, including speech and language therapy (SLT),
has been substantial.
Objectives: To review the changes to SLT services triggered by the COVID-19 pandemic
with respect to referral rates, service delivery and outcomes, as well as examining the
contribution of SLTs to the neurorehabilitation of COVID-19 patients.
Methods: Two surveys were distributed to Royal College of Speech and Language
Therapists (RCSLT) members exploring experiences of service provision at 6 weeks and
22 weeks after the pandemic was declared in the UK. Responses to closed-ended
questions, including questions regarding referral numbers were analyzed descriptively
and compared at the two time-points. A database comprising routine clinical data from
SLT services across the UK was used to compare information on patients receiving
services prior to and during the pandemic. Data on COVID-19 patients was extracted,
and findings are provided descriptively.
Results: Referrals to SLT services during the acute COVID-19 period in the UK were
substantially less than in the same period in 2019. A number of service changes were
common including adopting more flexible approaches to provision (such as tele-therapy)
and being unable to provide services to some patients. Database analysis suggests
fewer patients have accessed SLT since the pandemic began, including a reduction
in neurorehabilitation patients. For those who received SLT, the outcomes did not
change. SLTs supported a range of needs of COVID-19 patients. Treatment outcomes
for COVID-19 patients with dysphagia were positive.
Discussion: The pandemic has affected neurorehabilitation and SLT services broadly:
referral patterns are different, usual care has been disrupted and interventions have been
modified affecting the impact on patient outcomes both positively and negatively. Some
patients with COVID-19 require and benefit from SLT intervention.
Keywords: speech and language therapy, COVID-19, outcome measurement, service provision, disruption theory
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INTRODUCTION
Rehabilitation and enablement services have been modified
significantly over the last decade in response to changes in
demography and increasing care in the community, leading to
demand outstripping capacity progressively over many years.
People are living longer with complex health needs and
there is increased evidence of the impact of rehabilitation
services on improving independence and well-being leading to
greater expectations and demand (1). Following the outbreak
of severe acute respiratory syndrome coronavirus 2 (SARS-
CoV-2 or COVID-19) and the subsequent global health
emergency (2), neurorehabilitation services entered the response
when the requirement was already outstripping supply. An
important element of the multi-disciplinary approach to
neurorehabilitation is speech and language therapy (SLT), which
attends to the assessment and management of those with
speech, language, communication and swallowing disorders. As
such, this profession was similarly affected by the demand and
supply contention.
The evidence indicates a large and important role of
neurorehabilitation services in the response to COVID-19.
It is well-documented that the virus commonly affects the
functioning of the nervous system and patients sustain a degree
of ill-health for several weeks post-infection (3). Common
symptoms observed in post-acute COVID-19 patients include
dyspnea (or shortness of breath) and muscle weakness causing
mobility difficulties (4). Moreover, COVID-19 patients can
experience fatigue, neuropsychological and cognitive problems,
dysphagia (swallowing difficulties), and general impairments
in their activities of daily living (5). Rehabilitation services,
thus, are warranted and indeed critical for treating COVID-19
patients. Consequently, strains are put on non-COVID-19 related
rehabilitation services, especially those occupying hospital bed
spaces, as the need for re-organization arises following the
increase in patient admittance (6).
By the end of February 2020, the first case of within-country
transmission of COVID-19 in the UK was recorded and on
March 18, 2020, UK National Health Service (NHS) providers
were given the directive to postpone all non-urgent and elective
activity. By March 19, 2020 many community health services
were stopped. A UK-wide lockdown shortly followed on March
23, 2020, and by March 25, 2020, all NHS hospital visits were
suspended, and services were told to plan for the redeployment
of clinical staff, including speech and language therapists (SLTs),
to attend to critical COVID-19 related services (7, 8). Individuals
who were identified as being “extremely vulnerable” to catching
the virus and experiencing severely ill health or death, received a
governmental directive to “shield” and completely self-isolate for
the lockdown period (9).
As the spread of the virus accelerated and hospitalizations
surged, thus did the demand for SLTs to be part of the
team managing critically ill COVID-19 patients. Dysphagia (an
impairment in swallowing function) emerged as a frequent
complication in such patients with estimates of around 30% of
those admitted to hospital with COVID-19 needing a swallow
assessment (10), andmanywhowere intubated requiring swallow
rehabilitation (11). Not only does an impairment in swallow
function result in difficulties with oral feeding, but it is also a
risk factor for developing aspiration pneumonia, which has also
been documented in COVID-19 patients (12). However, early
evidence does indicate that dysphagic COVID-19 patients can
make a recovery following swallow rehabilitation (13) which
in the UK is carried out by SLTs. Some questions remain
as to the extent of late swallowing complications, potentially
arising from virus-induced bulbar nerve damage (14) which
may highlight the need for ongoing intervention. Thus, SLTs
are an integral part of the intensive care unit team (15) and
the longer-term rehabilitation team. Moreover, SLTs have a role
in the management of dysphonia, another frequently reported
symptom of the virus, reported in patients with mild to moderate
COVID-19 (16). Furthermore, high rates of difficulties with vocal
function following intubation has been reported (17). Thus, the
pandemic has had a wide-ranging impact on SLT services arising
from the suspension of many therapy services, the redeployment
of clinicians, and the demand for specialists within critical,
acute and rehabilitation services. Consequently, disruption to
SLT services has been noted.
The theory of disruption (18) suggests that a sudden break or
interruption of usual practice and break with established routines
and models may lead to innovation as well as unintended
consequences, both positive and negative. The Royal College of
Speech and Language Therapists (RCSLT), the professional body
for SLTs in the UK, was aware at an early stage that the pandemic
would lead to breaks with establishedmodels of service provision.
This offered the opportunity to examine the impact on service
provision and patient outcomes.
There are two key ways of learning from major disruption.
Firstly, being able to compare data, such as referral rates, patient
characteristics, care pathways and outcomes, during a period of
disruption with that recorded beforehand, is likely to give useful
insight into intended and unintended consequences. The second
source of information is the reactive experience of practitioners.
This paper aims to utilize both methods to explore the changes
to SLT practice and service delivery arising from the pandemic,
specifically by asking the following two research questions:
1. How has COVID-19 impacted on SLT both generally, and in
neurorehabilitation, in terms of (a) referral rates, (b) service
provision and (c) therapy outcomes?
2. What is the contribution of SLT in COVID-19 management?
METHODS
Amixed methods approach was taken, including the distribution
of two surveys to SLTs in the UK exploring their experiences
following the outbreak of the pandemic at two different time
points, and interrogation of a UK database (The RCSLT Online
Outcome Tool). Neither contribution to the database nor
participation in the survey was mandated and were not specific
to SLTs working in neurorehabilitation alone.
Surveys
Two surveys were developed using Survey Monkey (19) and
distributed to ∼17,000 RCSLT members through different
communication channels including newsletters and social media.
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The first survey was open between 23 April and 29 April 2020,
inclusive, and the second ran between 12August and 7 September
2020, inclusive. The questions for both surveys were developed
iteratively by a working group consisting of SLTs and piloted by
SLTs not involved in the development. They comprised open-
and closed-ended questions. The analysis of and findings from
the latter are reported here.
The surveys aimed to explore the experiences of UK-based
SLTs by asking a series of closed-ended questions. The first survey
included 15 questions, including 13 multiple choice questions,
referring to the nature of changes in roles, responsibilities and
duties, the extent to which intervention was being provided to
individuals requiring speech and language therapy, any changes
that were of benefit to clinical practice, service delivery and/or
patients. The second survey included 3 questions contained in
the first survey, and 46 additional questions about referral data
and those developed from the often-reported experiences from
the first survey, including teletherapy, workforce capacity and
the barriers service users faced when accessing services. For each
multiple-choice question in both surveys, participants were asked
to select all statements which reflected their experience, which
is analyzed descriptively regarding how often statements were
selected. The full versions of both surveys can be found in the
Supplementary Material.
To explore the impact of COVID-19 on SLT referral rates
across speech and language therapy services, the responses to the
questions on the second survey of “how many referrals did your
service receive for speech, language and communication needs in
the following periods” and “how many referrals did your service
receive for dysphagia in the following periods” (periods specified
as: 1 April−31 May and 1 June−31 July in 2019 and 2020) were
combined, and a percentage change across the 2 years calculated.
Data specifically for referrals from neurorehabilitation services
was not collected.
To examine the impact on service provision we present
findings from the surveys regarding reported experiences around
changes in the roles, responsibilities and duties of SLTs, the
provision of intervention and the barriers to accessing services,
alongside an analysis of changes observed in the ROOT data for
treatment episodes ending between 1 March 2019 and 31 August
2019 and 1 March 2020 and 31 August 2020, i.e. prior to and
during the pandemic.
The RCSLT Online Outcome Tool
The RCSLT had been supporting SLT services with routinely
collecting data prior to the pandemic. The national database,
the “ROOT” (20), supports SLTs from across the UK with
collecting and collating data on referrals, case mix, presentation
and outcomes of individuals of all ages receiving SLT. It
generates reports which contributes to quality assurance and
benchmarking (21). The data collected includes de-personalized
patient information, including: gender, age, medical diagnosis,
and descriptors on the swallowing or communication condition
[using codes given in the International Statistical Classification
of Diseases and Related Health Problems-10th Revision (22)
herein, “ICD10 codes”], as well as information from the Therapy
Outcome Measure (TOM) (23–26).
The TOM is designed to be a simple, reliable, cross-
disciplinary, and cross-client group method of gathering
information on the impact of enablement and rehabilitation. It
has been rigorously tested for reliability and clinical validity (23–
26) and comprises four domains, the first three of which are
based on the WHO’s International Classification of Functioning
(ICF) definitions of Impairment, Activity and Participation (27).
The fourth domain of well-being, of both the individual and the
carer, was added to the TOM due to the finding that having an
impact on well-being is an objective of most neurorehabilitation
services and thus needs to be separately identified in the outcome
measure. The TOM has an 11-point ordinal scale. A rating from
0 to 5 is made on each domain, where a score of 0 is profound,
3 is moderate and 5 is considered normal for the age, sex, and
culture of the individual (25). A score of 0.5 or ½ a point may be
used to indicate if the person is slightly better or worse than the
descriptor (23–26).
The ROOT is opt-in (i.e., it is not mandatory for all SLT
services to contribute to) and currently comprises data from a
range of service types including NHS, independent and third-
sector funded services. Timing of data entry is not regulated and
is dependent on the SLTs or support staff to input information
either “live” or periodically.
To examine the impact on service provision, the number and
proportion of episodes of care from every area of SLT, and those
of the 5 most frequently recorded neurological disorders (in
the 2019 period) were extracted from the ROOT data and are
compared with 2020 data descriptively.
To evaluate the impact of COVID-19 on therapy outcomes,
initial and final TOM ratings were extracted for episodes of care
from every area of SLT, and those of the most frequently recorded
neurological disorder for the same 2019 and 2020 period as
detailed earlier. Average changes in the TOMwere calculated and
are presented descriptively.
Finally, to inform on the contribution of SLT in COVID-
19 management, data from the ROOT on patients who were
recorded as positive for COVID-19 was extracted. This was
interrogated to explore the overall numbers of patients presenting
to SLT services (within the services that were contributing
data), with a diagnosis of COVID-19 (by age and gender) and
the focus of SLT intervention for these patients. The SLT role
in neurorehabilitation of COVID-19 patients was specifically
examined by analyzing the change in the ‘impairment’ TOM
before and after an episode of care of patients with a SLT
diagnosis of dysphagia secondary to COVID-19. These are
reported in categories which reflect the goal of intervention
of these patients (i.e., whether the impairment is expected to
improve, maintain at the same level, or if intervention is part of
a managed decline). The average change in the TOM ratings was
calculated and are presented descriptively.
Ethical Considerations
This project involved use of anonymised audit data to evaluate
current services as part of a service evaluation. SLTs provided
minimal de-personalized data on all referred patients e.g.,
age, gender, diagnoses, and TOM ratings at the beginning
and end of an episode of care to the ROOT database, and
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thorough information governance procedures were adhered to.
Participants in the survey were anonymous and there were no
inducements to take part.
RESULTS
Surveys of RCSLTmembers conducted in April 2020 andAugust-
September 2020 received 544 and 413 responses, respectively. At
the time of reporting, the ROOT contains data on 45,174 episodes
of care from 39,534 patients, which are from 34 SLT services
across the UK. Here, both sources of data are combined to answer
the specific research questions.
The Impact of COVID-19 on SLT Referral
Rates
Table 1 shows the number of referrals received for speech,
language and communication needs (SLCN) (from 68 SLT
services) and dysphagia (from 52 SLT services) and the change
in referral rate between the two time periods prior to and
during the pandemic, as reported by participants of survey 2. It
indicates a substantial reduction in referrals for SLCN (−31.10%
change) although a relatively stable rate of dysphagia referrals
(−1.29% change).
The Impact of COVID-19 on SLT Service
Provision
95.6% of respondents (520/544) to the first survey said that
the pandemic was having an impact on their professional roles,
responsibilities and duties. They reported changes including use
of different methods of service delivery, and a reduction in
clinical caseload (referrals and serviced current caseload) being
most commonly cited.
Table 2 shows several common changes to service delivery
experienced by SLTs during the acute COVID-19 period (April
2020), with nearly two-thirds of respondents identifying that an
altered method of service delivery occurred in this period (63.1%),
and almost half reporting that they were no longer seeing patients
directly (face-to-face) (48.9%).
Table 3 explores the service provision changes in more detail
but focuses on the provision for patients who were continuing
to receive intervention in April 2020. The most commonly
reported change to provision was more therapy being delivered
remotely via telephone consultations (60.7%), with a high volume
of respondents also citing the following changes: patients seen
less frequently (44.5%), more video consultations (43.6%), more
advice given to others (41.2%), alternative delivery of care due
to PPE considerations (38.2%) and providing information via
leaflets (28.3%).
Respondents reported that a significant proportion of patients
were not receiving intervention, when in normal circumstances
they would, for the both the acute COVID-19 period (April
2020) and later in August-September (2020). This demonstrates
a negative shift over time, in that 74.6% responded that they did
have patients who should be receiving intervention but who were
not in April, which increased to 83.5% in the second survey in
August-September. See Table 4.
The barriers to providing these patients with services are
given in more detail (Table 5), across the two time points. The
most frequently cited barrier in April was that services could
TABLE 2 | Frequently reported changes experienced by SLTs in April 2020, and
number and percentage of respondents identifying these.
Changes reported n Percentage of all
respondents (%)
Altered method of service delivery
(e.g., remote delivery)
343 63.1
Reduction in routine clinical caseload 340 62.5
Reduction in referrals for patient/client
groups on routine clinical caseload
278 51.1
No longer seeing patients directly 266 48.9
Restriction to the location of service
delivery caused by closure of usual
place of work (e.g., school, clinic)
240 44.1
Increased non-clinical tasks and/or
projects
228 41.9
TABLE 3 | Six commonly reported changes in service provision for patients on
routine caseloads who were continuing to receive intervention in April 2020, and
number and percentage of respondents identifying these.
Change in provision n Percentage of all
respondents (%)
More remote provision of
therapy—via telephone consultations
330 60.7
Patients seen less frequently 242 44.5
More remote provision of
therapy—via video consultations
237 43.6
More advice provided to others 224 41.2
Care being delivered in a different way
due to considerations about PPE
208 38.2
Providing information via leaflets 154 28.3







2020 referrals expressed as a




SLT need SLCN 10,081 6,946 68.9 −31.1
Dysphagia 5,020 4,955 98.7 −1.3
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TABLE 4 | Number of respondents reporting whether they had patients on their caseload who were not receiving intervention but would usually do so.
April 2020 August-September 2020




Yes 406 74.6 313 83.5
No 97 17.8 53 14.1
Not applicable/no response 41 7.5 9 2.4
TABLE 5 | Number of respondents reporting common barriers to accessing services for patients on their caseload who were not receiving intervention.





Staff availability 51 9.4 69 18.4 +9%
No suitable venue/closure of usual place of work
(e.g., school, clinic) or service
181 33.3 126 33.6 +0.3%
Closure of caseloads 84 15.4 * *
As a result of changes to service delivery based on
national guidance or local policy (of the SLT service
or another setting/service)
203 37.3 160 42.7 +5.4%
Limited access to correct type of PPE 30 5.5 14 3.7 −1.8%
Risks associated with aerosol generating
procedures (AGP)
87 16.0 * *
SLT not able to provide teletherapy/service does not
have access to teletherapy
42 7.7 43 11.5 +3.8%
Patients do not have access to teletherapy 115 21.1 196 52.3 +31.2
Teletherapy was not appropriate * * 200 53.3
Patients not wishing to continue with intervention at
the current time
160 29.4 160 42.7 +13.3%
Patients on my caseload have been discharged with
advice to re-refer if required
64 11.8 * *
Individual/household was shielding * * 91 24.3
Families’ health and well-being needs * * 50 13.3
Lack of access to interpreters/bilingual co-workers * * 32 8.5
Other 79 14.5 58 15.5 +1%
No response 144 26.5 65 17.3 −9.3%
N.b respondents could select more than one option, therefore, the percentages do not total 100. *Question not included on survey.
not be provided due to national guidance or local policy (37.3%).
This was still a common issue in August-September (42.7%) but
moreover, there was an additional issue that teletherapy was not
appropriate for some of these patients in the August-September
survey (53.3%).
The second survey sought to explore these changes in service
provision in more detail, such as the use of remote consultations
by the profession. Respondents estimated that, on average, 46.2%
of individuals on SLT caseloads were receiving services virtually
(e.g., via teletherapy) which had been unusual before and at an
earlier stage in the pandemic.
Data from the ROOT on completed episodes of care is
presented in Table 6 detailing episodes recorded for patients with
any of the 5 most common neurological disorders referred for
SLT in the 2019 and 2020 periods. The number of episodes is
also expressed as a percentage change across the 2 years. This
illustrates a distinct reduction (of 1,523) in episodes of care either
recorded or entered into the ROOT in the 2020 period compared
with the 2019 period.
The Impact of COVID-19 on SLT Outcomes
Table 7 shows the mean and median change in the TOM
for all the ROOT data for both time periods in 2019
and 2020, as well specifically for stroke patients. The tables
indicate that outcomes were largely positive and consistent
in both cohorts. Interestingly, the data suggests that stroke
patients made greater progress in their therapy in 2020
than in 2019.
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TABLE 6 | Completed episodes of care recorded in ROOT, for whole database
and broken down for the 5 most common neurological disorders, in the 2019 and




















Stroke* 619 147 -
% 16.9% 6.9% −10.0
Dementia* 255 42 -








% 1.5% 1.3% −0.2
Brain tumor* 23 1 -
% 0.6% 0.0% −0.6
*Indicates where a group of ICD10 codes have been counted together, which refer to a
general condition, for example “Stroke” includes episodes recorded as relating to: Stroke,
not specified as hemorrhage or infarction, and Cerebral Infarction.
The Contribution of SLT in COVID-19
Management
The data on 163 individuals with a confirmed COVID-19
diagnosis (Figure 1) indicates that more males than females were
referred, and a greater proportion of people from the older age
group required SLT services, which is in line with the reported
gender and severity differences related to COVID-19 requiring
hospitalization (28).
The data in Table 8 describes the SLT management required
for the patients referred with a positive diagnosis of COVID-
19, and the average change in the TOM. These individuals
were treated for dysphonia, dysphagia, dysarthria and cognitive
communication disorder. Some patients were orally intubated
and/or had a tracheostomy as part of their management requiring
assistance with oral hygiene. This shows some variability in the
degree of change for different conditions, however clinically
significant changes were reported for most.
Where possible, COVID-19 patients were coded for the
objective of their SLT intervention: whether their impairment
was anticipated to “improve,” “sustain,” or where they may have
a “managed decline,” depending on the underlying medical
condition causing the speech, language, communication
or swallowing disorder. Table 9 provides data on the
respective average outcomes of COVID-19 patients with
dysphagia, within each intervention objective. The highly
significant positive change in impairment rating of those
TABLE 7 | The average change in TOM scores for all ROOT data and specifically stroke data for both time periods in 2019 and 2020.
Time period n TOM domain
Impairment Activity Participation Well-being Carer
well-being
All ROOT data 2019 3,663 Average
(mean)
change




0.00 0.50* 0.00 0.00 0.00
All ROOT data 2020 2,140 Average
(mean)
change




0.00 0.50* 0.50* 0.00 0.50*
Stroke data 2019 619 Average
(mean)
change




0.00 0.00 0.00 0.00 0.50*
Stroke data 2020 147 Average
(mean)
change




1.00* 1.00* 1.00* 0.50* 0.50*
*An increase of 0.5 or more on the TOM is a clinically significant change (21) and is marked with an asterisk.
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FIGURE 1 | Proportion of 163 patients with confirmed COVID-19 diagnosis at the point of referral to speech and language therapy, by gender (A) and age group (B).






n 69 174 83 30 82
Average (mean)
change
1.02* 0.83* 0.85* 3.83* 0.19
Average (median)
change
0.00 0.25 0.00 4.00* 0.00
NB. Individuals may have more than one SLT requirement. *An increase of 0.5 or more on the TOM is a clinically significant change (24) and is marked with an asterisk.
TABLE 9 | The number of patients with dysphagia and COVID-19, with identified specific intervention objectives (improvement, sustain, manage decline), with the
corresponding median impairment scores at the start and end of treatment, and median change over time.








Improve 26 3.00 4.50 1.50*
Sustain 16 3.00 3.00 0.00
Managed decline 14 2.00 1.00 0.00
Not specified 25 3.50 4.00 0.00
*An increase of 0.5 or more on the TOM is a clinically significant change (24).
on the “improve” track may be associated with the role
that SLTs have in dysphagia management of COVID-19
patients, forming a crucial part of the multi-disciplinary team
(MDT) (29).
DISCUSSION
Despite the challenges posed on the UK healthcare system
resulting from the COVID-19 pandemic, speech and language
therapists have been able to adapt their ways of working,
develop specialist skills and innovate strategies to manage the
consequences of a new disease. On the other hand, speech
and language therapy services in the UK have, for several
reasons, reduced over the acute-stage of the pandemic, and it is
probable that a large proportion of patients have not received the
provision they would have normally been offered. The findings
we present here provide a broad insight into the ways in which
this has occurred from a national perspective, which appear very
much in line with reports from other UK-based allied health
professions (30).
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Investigating such changes, and thus assessing the impact
of the pandemic, is challenging. One of the advantages of a
dedicated and flexible national database, such as the ROOT, is
that it provides information which can be interrogated when
there is a major unanticipated disruption, such as a pandemic.
This allows for analysis of the impact on services and patients
exposing negative and positive effects. By comparing information
gathered during the first wave of the COVID-19 crisis in the UK,
with that from an identical time-period in 2019, we have been
able to illustrate some of the impacts of the outbreak on usual
care. The survey of professionals provides further information
explaining and complementing that gathered on the database and
assisting with its interpretation. Whilst we acknowledge that we
cannot generalize the findings from our investigations too widely
due to the opt-in and non-stratified methodologies used, it can
nonetheless offer a unique perspective on UK SLT provision both
before and after the onset of the COVID-19 pandemic. In so
doing, we have been able to investigate specific questions posed,
regarding its impact.
Changes to Referrals to and Service
Delivery of Speech and Language Therapy
Overall, the data presented here suggests that SLTs have observed
substantial changes to the number of referrals to SLT, and
the amount and process of therapy that they have delivered,
following the UK’s COVID-19 response. This is perhaps not
surprising given the national restrictions and is in line with
reports on the general landscape of non-COVID-19 NHS care
during the pandemic (31). Indeed, it is clear from both datasets
that, similar to other services (30), there has been a reduction in
routine SLT caseloads. This may in part be caused by fewer new
referrals for the assessment and treatment of speech, language
and communication disorders. Additionally, it is likely to be an
effect of SLTs being unable to provide intervention to individuals
on existing caseloads following the closure of settings during
lockdown, and patients opting not to access services at this
time. The findings from the survey provide insight into these
changes, specifically the 2019/20 year-on-year referrals, but also
the finding relating to the high proportion of services which
had to adopt different methods of service delivery. There has
been an increase in the provision of services in different settings
delivering therapy remotely using a variety of technologies, which
is likely to have disadvantaged those from socially deprived areas
(32) or the very elderly (33). The “switchover” to telehealth
has been one of the widest reported changes to healthcare in
this period (34, 35), despite its subsequent problematizing with
regard to how this approach may exclude many patients without
access to technology (36). These issues are likely to underpin
the reduction in treatment episodes recorded on the ROOT for
the pandemic.
Impact on Neurorehabilitation Speech and
Language Therapy Services
It is possible that some neurorehabilitation patient groups have
been more severely affected by the pandemic, in terms of
receiving therapy. We found that not only had the number
of episodes of care for stroke patients reduced substantially
between the 2019 and 2020 periods (619–147), the proportion
of episodes of care for stroke in the 2020 period was 10% less
than the year before. Whilst it is possible that over time, as more
data is imported into ROOT, this pattern adjusts, it is plausible
that given the COVID-19 healthcare response, these patients
are simply not being referred to SLT. Early assessment and
management of stroke-related dysphagia and language difficulties
by SLTs reduces pneumonia and mortality (37) and there is
evidence that persistent aphasia has a more favorable outcome
if provided with SLTs at an early stage (38). Therefore, this
finding of reduction in referrals is of concern. One explanation
could be that it is simply not safe for SLTs to deliver care to
these groups in the COVID-19 context (39), or these patient
groups may be less able to rapidly adapt or adhere to tele-
therapy (40), leading to less engagement in this period. However,
the reduction observed in stroke cases from SLTs is in line
with other reports showing a concerning reduction in stroke
admissions across the UK throughout the lockdown period
(41). Similarly, the data shows a reduction in episodes of care
for dementia patients, but relatively consistent representation
of patients with Motor Neuron Disease (Amyotrophic Lateral
Sclerosis), Parkinson’s disease and those with brain tumors. This
could potentially indicate where SLT services were particularly
affected, for example, with limited access to care homes to see
patients with dementia, or reduced capacity in acute hospital care
for those with strokes, in comparison to the likely domiciliary
care for other neurorehabilitation patients with chronic or
progressive diseases.
Impact of the Pandemic on Routine
Therapy Outcomes
The findings also show, interestingly and perhaps surprisingly,
that the average improvement on the TOM from 2019 is indeed
maintained, and in some cases, bettered, in 2020. It is clear
that SLTs continue to make an impact for patients, regardless of
the challenging circumstances. For the stroke patients recorded
in the ROOT, the comparative average change in outcomes
between 2019 and 2020 is notable; the median change in 2019 for
impairment, activity and participation was 0.0, which increased
to 1.0 in 2020, reflecting a positive gain of 2 half-points which
is clinically significant. This is of particular interest and requires
further investigation to ascertain the reasons. Yet, it is important
to note that those receiving SLT in 2020 during the pandemic
may be a subset of those who would do so in usual times.
One consideration is that those who received intervention may
have been a “less impaired” subset. It is plausible, for example,
that patients with more complex needs, co-morbidities and/or
those who were subject to the “shielding” regulations may have
been less able to engage with services during the immediate
period after the UK lockdown. Thus, this may reflect the therapy
outcomes from those who were less at risk of the virus in terms
of health, i.e., fewer co-morbidities and who may potentially
make greater gains anyway, or those who had greater support
around them from relatives/carers working at home. Another
consideration may be that those from less socially deprived
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areas were able to access therapy more readily than those in
less-affluent areas, using virtual means (32). Furthermore, some
individuals may also have experienced improved access with
the extension of remote delivery of services, such as those who
would ordinarily find it challenging to attend appointments,
due to caring responsibilities, or travel restrictions. Another
explanation could be that for those engaging in teletherapy, skills
acquired through intervention whilst in the home were more
easily practiced and embedded than when therapy is confined to
a clinic.
Contribution of Speech and Language
Therapists in Managing COVID-19
Our findings illustrate that SLT plays an important and
positive role in the treatment and rehabilitation of patients
with COVID-19 especially for those presenting with dysphagia,
whose impairment can improve—and potentially resolve, for
a subset of patients. The survey, similar to other reports
(42), indicates that SLTs have adopted new roles associated
with treating particular symptoms of COVID-19, such as
communication with tracheostomy, and different expressions
of dysphagia. The SLT profession has a growing body of data
about the presentation (Table 8) and outcomes (Table 9) of
individuals with COVID-19 receiving SLT intervention for the
consequences of this new disease, which is further supported in
the literature (12–14, 43, 44).
Going forward, it would be valuable to be able to gather
information on the new ways of working from the perspective
of those both receiving and in need of the service. A limitation of
the study presented in this paper is the omission of information
from those receiving services during this period. The RCSLT
are, at the time of writing, conducting a survey to gather the
experiences of individuals with speech, language, communication
and swallowing needs, and their families, but the findings are
not presented in this paper. Nonetheless, charities and patient
associations have been collecting information on the impact
of COVID-19 on their members. The impact on services was
detailed in surveys conducted by the Patients’ Association and
the Stroke Association. The latter survey (45) received a response
from 1,500 stroke survivors and carers in England, 60% of whom
felt that they received less support from health and care services
than was usual. Sixty-eight percent of respondents reported that
they felt more anxious and depressed and more than three
quarters of carers said they were providingmore care and support
during the pandemic than prior to it. Nine hundred and fifty-
three patients responded to the survey conducted by the Patients’
Association (46) which found that 67% of respondents reported
that they were not seeking medical advice or intervention either
because primary care services were more difficult to access or
because they were avoiding contact with healthcare professionals
due to anxiety related to the pandemic. These findings were not
surprising givenwhat the survey reported in this paper along with
what the ROOT data indicates.
There are additional limitations to our study that should be
considered when interpreting the results presented in this paper.
As with all surveys, we must be cautious in our assumption that
these respondents are representative of the experiences of the SLT
profession within the UK. Furthermore, even though the ROOT
is intended to be used by SLTs for routine data collection, it is
likely that the disruption experienced by services has impacted on
the ability to record outcomes data for all individuals receiving
SLT compared with usual times, which may be affecting the
completeness of the data in the national database. It will be
important to repeat this analysis in future to explore any changes
to the retrospective data. The nature of the data in the ROOT
also may impede its generalizability, not least with respect to the
specific UK context, but also across services within the UK, since
it captures a subset of speech and language therapy services.
Despite this, we have presented an overview of the impact
of COVID-19 on the role and clinical practice of SLTs in the
UK, providing evidence of consequences of the pandemic, both
positive and negative. The outcomes of SLT patients both prior
to and during the pandemic present some interesting issues and
areas for further exploration, in addition to highlighting the
contribution of SLTs in COVID-19 rehabilitation. The recovery
of the provision of health services once the pandemic wains
will need to consider how to support those who did not
receive SLT support for their speech, language, communication
and swallowing needs or for their rehabilitation in a timely
manner along with incorporating the new ways of working into
care pathways.
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